Cheap compounded tirzepatide

The market for compounded tirzepatide has changed significantly. While several telehealth providers still offer it at prices starting around $199 to $300 per month, you should know that the FDA recently declared the tirzepatide shortage over. This means the legal pathway for pharmacies to mass-produce cheaper, generic-like copies is closing, so your options may be limited in the near future.

Here are the current options available to help you compare costs and providers.

To navigate this landscape effectively, consider these strategies based on your personal circumstances:

• If you have insurance that might cover it: Your first step should be to check with your provider. If Zepbound or Mounjaro is covered, using a manufacturer's savings card can bring your cost down to as little as $25 per month. This is often the cheapest and safest route.
• If you are paying out-of-pocket: The most affordable way to get brand-name medication is through LillyDirect, the manufacturer's own pharmacy program. You can get the 2.5 mg and 5 mg vials for $349 and $499 per month, respectively. This is a strong alternative to compounded versions because it offers the certainty of an FDA-approved drug.
• If you still choose compounded tirzepatide: Do your research. Compare the all-inclusive monthly costs of the telehealth providers listed in the table. Before you sign up, ask which specific 503A or 503B pharmacy is preparing the medication, as this is a key indicator of quality and oversight. Be aware that due to the FDA's recent decision, the availability of these services may change suddenly.